Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Treatment-resistant Depression in Mexico
NCT01868802Phase 2Unknown
- Start
- Sep 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in treatment-resistant depression (TRD). Status: unknown.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT01868802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868802.